fbpx Skip to main content


A breakthrough partnership to develop unique natural biocontrol products from microalgae.

By News

Biotechnology companies, Algalíf Iceland and ImmunRise Biocontrol France have entered into formal discussions regarding a long-term strategic partnership for the development of a large-scale microalgae industrial center that will be the essential component for the development of new types of biocontrol solutions from microalgae for various sectors of the agriculture industry.

Starting the 1st of September 2023, along with the successful bid for EUREKA Eurostars 3 – Call for their project SEEDS OF LAVA (SOLA), both companies will aim to extend their innovative development by complementing their current strengths. The strategic partnership will establish a strong base for the development of new natural biocontrol products dedicated for plant protection in the agriculture market. The global biocontrol market turnover is valued at USD 6.5 Billion in 2022 and is expected to reach USD 13.7 Billion by 2027.

Joint Press Release Algalif-IBF


Superfood from the tube aquarium

By Algalif in the media, News

Alglaíf is featured in the latest issue of Schott Soulutions Magazine:

“With sustainable farming and the avoidance of animal products becoming important aspects of personal well-being, there is a rising interest in vitamin-rich, ecologically friendly superfoods like microalgae. Cultivated in glass tubes made of specialty glass, experts believe this single-celled organism could be the future of human health.”

Read more here.


A truly international hub of knowledge.

By News

Construction on Algalif´s 12.500 m² sustainable Natural Astaxanthin production facilities in Iceland are going as planned. The company started its 30 million US$ expansion in the summer of 2021 and the plant will be fully operational by the end of 2023.  

Algalif´s current production capability is 1.500 kg of pure Natural Astaxanthin annually. After the expansion, the yearly production will be 5.000 kg of pure astaxanthin. Thereby, Algalif will be the world’s biggest producer of Natural Astaxanthin from microalgae. The company only uses green geothermal energy and pristine natural Icelandic water.  

The new plant will also make Algalif the most sustainable, and most technically advanced Natural Astaxanthin producer in the world. This is in accordance with Algalif´s goals to be a leader in sustainability and quality in the microalgae business, as well as a reliable supplier of Natural Astaxanthin at a competitive price.

Algalif will be the world's biggest producer of natural astaxanthin when its new production plant in Iceland will be operational by the end of 2023.

Algalif will be the world’s biggest producer of natural astaxanthin when its new production plant in Iceland will be operational by the end of 2023.  

A revolutionary AstaBead™ 5% natural astaxanthin beadlets.

By News

Algalíf and Divis Nutraceuticals have recently introduced a partnership that has led to a new and revolutionary product called AstaBead™.  Now there is a new and improved version. 

It is a 5% natural astaxanthin beadlet, which is a type of microencapsulated oleoresin that contains natural astaxanthin. It outperforms other options in various applications due to its exceptional features such as ease of handling and uniformity.  

The Astabead™ 5% comes in both compressible and cold-water dispersible forms that can be used for everything from tablets and capsules to gummies, nutritional bars, and drinks.

Algalíf publishes an Overview of Human Clinical Studies on Natural Astaxanthin. 

By News

The biotechnology company Algalíf Iceland has published a comprehensive Overview of Human Clinical Studies on Natural Astaxanthin. These studies have been carried out by scientists around the world in recent decades and up to the present day. It is the most comprehensive publication of its kind ever available. 

Algalif’s scientists reviewed a large number of studies and selected the 72 best ones based on methodology and scientific reliability. The main categories are Oxidative balance, Cardiovascular health, Healthy skin, Healthy Aging, Fighting Diabetes, Recovery from Heavy Exercise, Combinatorial Applications and Food Applications.  

The publication contains various information about astaxanthin and research on the substance in humans. There are also extracts from dozens of studies and references on where to access the studies themselves. The Natural Astaxanthin Human Clinical Studies Overview can be accessed and downloaded from Algalif’s website (www.algalif.com). 

Algalíf has published the most comprehensive ever available Overview of Human Clinical Studies on Natural Astaxanthin.  

Algalif is a CarbonNeutral® certified Company.

By News

Since last year, Algalif Iceland is a Certified CarbonNeutral® Company. This is in accordance with the company’s Environmental Policy Manifesto by the internationally renowned CarbonNeutral® Protocol. Algalif produces plant microalgae using clean natural water and green geothermal energy. All Algalif´s astaxanthin products are also certified as CarbonNeutral®.  

Algalif Iceland is now a Certified CarbonNeutral® Company. This is in accordance with the company’s Environmental Policy Manifesto by the internationally renowned CarbonNeutral® Protocol. Algalif produces plant microalgae using clean natural water and green geothermal energy. All Algalif´s astaxanthin products are also certified as CarbonNeutral®. 

Algalif choose CarbonNeutral® as a green certification partner based on its outstanding reputation. Among other international companies with the same certifications are Microsoft,  Logitech, and Sky.

CarbonNeutral® has played a critical role in enabling clients to confidently make clear and credible claims about their climate programs and navigate the complicated and rapidly developing landscape of voluntary climate action. 

Algalif is the only Natural Astaxanthin producer in the world that is certified as a CarbonNeutral® company. 

Original Study by Algalíf Scientists on Asta Quantification Reproducibility

By Articles, News

Accurate quantification of astaxanthin is an integral part of the quality control system in the production of this compound. It is essential for both producers and customers that the true amount of astaxanthin is stated on a product label. However, astaxanthin quantitative analysis is prone to high variability between laboratories. One reason for this is that astaxanthin is not a single molecule but a mix of geometrical variants (isomers).

An original study performed by the Quality Department of Algalif Iceland ehf. revealed that these astaxanthin isomers can transform into each other depending on the conditions of the analysis. The chemical behavior of astaxanthin greatly affects its quantification and explains poor between-lab reproducibility which impacts the whole astaxanthin industry.

 The original paper is published in Molecules and accessible through the link.

Dr. Oleksandr Virchenko of Algalíf.


Dr. Tryggvi Stefánsson

Dr. Tryggvi Stefánsson of Algalíf.

Algalif for initial public offering in 2025.

By News

The Board of Directors of biotech company Algalif agreed on its meeting on December 15th to start preparations for the initial public offering (IPO) of the company scheduled for 2025. The board has mandated Hamrar Capital Partners to manage the preparation process and provide strategic guidance. At the company´s board meeting, Baldur Stefánsson, Managing Partner of Hamrar Capital Partners, was voted as Algalif´s new Chairman of the Board.

Algalif is currently starting up its 7.500m² expansion, bringing the total size of its production facility up to 12.500m², quadrupling the company´s previous production capacity of its flagship product Astalíf™ natural astaxanthin. The new facility will be the largest and most technically advanced natural astaxanthin production facility in the world, with a total investment of roughly 32 million US$.

All operations will continue to be sustainable, as in the production process CO2 is converted into oxygen by the algae through photosynthesis.

Algalif is a carbon-neutral certified company and only uses green geothermal energy for the astaxanthin production process, supplied by Icelandic power company HS Orka via the parties´ long-term power purchase agreement.

The expansion has been going according to plan and the first processing systems in the new plant are already online. The new facility will help us establish Algalif as the clear global leader in the production and marketing of natural astaxanthin. Furthermore, it will allow us to put even more focus on our research and development into other valuable algae products and address new markets,” says Orri Björnsson, Algalif´s CEO.

We are very excited by Baldur Stefánsson joining our BoD as chairman, and the future of Algalif now that we will start to ramp up production in our new state-of-the-art plant. The planned IPO will allow us to accelerate growth and strengthen our R&D efforts, to the benefit of our customers as well as other stakeholders.,” says Kenneth Bern, CEO of HeTe Invest AS, Algalif’s owner.

Close Menu

Algalif Iceland ehf. is committed to ensuring the security and protection of the personal information that we process, and to provide a compliant and consistent approach to data protection. Under the General Data Protection Regulation (GDPR) (EU) 2016/679, we have a legal duty to protect any information we collect from you. To learn more, go to www.algalif.com/privacy-policy